Viz.ai has unveiled its new AI-powered Pulmonary Care Suite, designed to enhance disease detection and streamline workflows in hospitals.
The Viz Pulmonary Suite integrates both acute and chronic pulmonary care workflows into a unified platform that connects with electronic health record (EHR) systems. This innovation aims to minimize missed diagnoses and treatment delays for critical pulmonary conditions such as chronic obstructive pulmonary disease (COPD), pulmonary embolism, and lung nodules.
Equipped with advanced AI tools, the platform can identify pulmonary embolisms directly from medical imaging scans, facilitating quicker clinical decision-making and ultimately improving patient outcomes. The suite also features chart summarization capabilities, allowing healthcare professionals to swiftly access patient information and recommended actions based on established clinical guidelines.
This launch is part of a broader trend toward the adoption of AI-driven workflow automation and clinical decision support tools in healthcare, particularly in specialties that require prompt diagnosis and coordinated care. As Viz.ai continues to expand its reach—currently serving nearly two-thirds of the U.S. population through approximately 2,000 hospitals—the implications for enhanced patient care are significant, potentially transforming how pulmonary conditions are managed across healthcare systems.